Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BRVE | DRVN |
|---|---|---|
| Price | $21.35 | $11.65 |
| Change today | ▲ 0.38% | ▼ 0.26% |
| Market cap | $1.92B | $1.92B |
| Return, 3 months | – | -23.0% |
| Return, year to date | – | -21.4% |
| Return, 1 year | – | -24.0% |
| P/E (TTM) | -3.5 | 11.7 |
| P/B | -20.0 | 2.3 |
| P/E percentile vs own 5y | 81st | 63rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -3,833.9% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +111.9% | +24.5% |
| Analyst buy share | 100% | 22% |
| RSI (14) | 39 | 38 |
| 30-day volatility | 93.2% | 35.8% |
| Max drawdown, 1 year | -32.7% | -39.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
